|Dr. Byron Benton Lends Voice to PHEN's South Carolina Disparity Rally|
Dr. Byron Benton, Senior Pastor at Mount Moriah Missionary Baptist Church raises awareness about prostate cancer early detection screening and urges people to visit PHENPSA.com for information.
|Grant Hill - NBA Hall of Fame Player Supports South Carolina Rally|
Grant Hill, NBA Hall of Fame Player and Atlanta Hawks Executive raising awareness and knowledge about prostate cancer early detection and mobilize action to eliminate the prostate cancer crisis.
|Clinical Trials eNewsletter|
Prostate cancer is a highly inheritable disease with large disparities of incidence rates across different racial groups. It occurs when genetic changes cause cancerous cells to develop in the prostate. Genetic tests can detect these changes.
|PHEN's Georgia Prostate Cancer Disparity Rally A Success|
The Georgia Rally was hosted during the month of May.
The final report is now available.
|Unleash the Power of Your Own Immune System|
Clinical Trials eNews: In this newsletter, we will discuss two types of IO therapies, which are engineered to increase cancer killing efficiency. The first is Chimeric Antigen Receptor (CAR) T-cell therapy and a second is Bi-specific T-cell engager antibodies (BiTEs).
|PHEN Member News and Highlights|
PHEN survivor network member Arnold Merriweather and his brother Erskine participated in Amgen's Every Patient Counts, Every Story Matters campaign and more news from other survivors.
Read Member News and Highlights.
|South Carolina Prostate Cancer Disparity Rally Coming in July|
PHEN's prostate cancer disparity rally will move to South Carolina in July where leaders and patients will join PHEN to raise awareness and mobilze ongoing educational efforts to address the disparity within SC communities.
|The 18th Annual African American Prostate Cancer Disparity Summit Coming in September|
PHEN will hosts its 18th Annual Summit virtually on September 7th, 14th, 21st and 28th. Please mark your calendars nows.
|Radioligand Therapy Webinar|
Dr. Keith Crawford discusses basics of Radioligand Therapy and Dr. Neil Fleshner talks about the role of precision RLT in treating metastatic castration resistant prostate cancer (mCRPC).
|Rep. Billy Mitchell - Georgia Rally|
President of the National Black Caucus State Legislators joins PHEN in the Georgia Prostate Cancer Disparity Rally.
|Rev. Dr. Kevin Murriel - Georgia Rally|
Senior Pastor of Cascade United Methodist Church in Georgia emphasizes that prostate cancer is a crisis in Black America and encourages you to get information about early detection, treatments and clinical trials.
|Milton Little - Georgia Rally|
Survivor and President of United Way Atlanta lends his voice to the prostate cancer disparity rally in Georgia.
|Bishop Thomas Brown - Georgia Rally|
A prostate cancer survivor and Presiding Prelate of the CME Church, Sixth District, Georgia encourages African American men to get screened for prostate cancer.
|Radioligand Therapy (RLT): Novel Targeted Prostate Cancer Management|
Join PHEN on Wednesday, May 11th at 6:30pm to learn the basics of Radioligand Therapy and how it is used to treat prostate cancer.
|Meet Dr. PSA|
Prostate cancer early detection screening saves lives. Visit PHENPSA.com for Life Saving information.
|Rev. Dr. Howard-John Wesley Speaks about his Prostate Cancer Risk|
Rev. Dr. Howard-John Wesley speaks about his prostate cancer risk and encourages all men to fight prostate cancer right now!
|Prostate Cancer News|
Read our latest Prostate Cancer News and PHEN Highlights.
|Diagnosed with prostate cancer?|
If you or a loved one have been diagnosed with prostate cancer, understanding the cancer risk level is critical in choosing the right treatment. Prostate cancer can range from very low to very high risk, and treatments can range from "no treatment" to "aggressive treatment."
Understand your prostate cancer risk level here
|Managing Sexual Health as a Prostate Cancer Survivor|
Dr. Arthur Burnett from Johns Hopkins University School of Medicine provides presentation on managing sexual health for prostate cancer patients.
|Hormone Sensitive Prostate Cancer|
Men with metastatic castration-sensitive prostate cancer (mCSPC) may qualify to participate in the TALAPRO-3 clinical trial researching a potential treatment for mCSPC with a DNA damage repair (DDR) gene alteration. Watch Now
|Pastor Clifford Jones, Sr Speaking Out at the Disparity Rally|
Pastor Clifford Jones, Sr., Friendship Missionary Baptist Church in Charlotte, North Carolina speaks about how Prostate Cancer is a Crisis in Black Communities.
|US Congresswoman Alma Adams Speaking Out at the Disparity Rally|
United States Congresswoman Alma Adams talks about PHEN online resources available to educate about prostate cancer.
|Dr. Daniel George Speaking Out at the Disparity Rally|
Dr. Daniel George, Duke Cancer Institute in Durham, North Carolina speaks about importance of early detection screening for African American Men.
|Pastor Harshaw Speaking Out at the Disparity Rally|
Pastor Dumas Harshaw, Jr., PhD from First Baptist Church in Raleigh, North Carolina expresses that COVID-19 is not the only disease ravaging black men.
|Dr. Matthew Nielsen Speaking Out at the Disparity Rally|
Dr. Matthew Nielsen, UNC Lineberger Cancer Institute in Chapel Hill, North Carolina talks about knowledge in treatment options is Key.
|A New Class of Treatment Therapies for Prostate Cancer Patients|
Immune-Oncology (IO) is a type of immunotherapy which increases the ability of one’s immune system to fight cancer.
|Exciting New Treatment Breakthroughs|
Prostate cancer clinical trials using Prostate-Specific-Membrane Antigen (PSMA) are ushering in a new generation of treatment therapies and diagnostic tools offering breakthrough benefits for patients.
|Barney Morris Survivor Story|
PHEN Network member Barney Morris speaks about his prostate cancer journey at the American Society of Radiation Oncology (ASTRO) Annual Meeting.
|Webinar: Making Clinical Trials Work For You!|
Clinical trials are important treatment options all along your prostate cancer journey.
Dr. Keith Crawford presents clinical trial opportunities that are available and how to make them work for you.
|Understand Your Prostate Cancer Risk Level|
Risk levels are determined by PSA Numbers, Biopsy Results, Gleason Scores, Grade Groups and Cancer Stage.
|PSMA, What It Is and Why It Matters To Prostate Cancer Patients|
Dr. Keith Crawford explains differences between PSA and PSMA, Dr. Michael Morris discusses successful VISION clinical trial and Dr. Michael Groaning discusses Amgen's AMG160 clinical trial.
|PHEN Survivor Network Spotlight: Phillip Frazier|
It was bad enough facing the impact of a prostate cancer diagnosis in 2015, observed survivor Phillip Frazier, but the Covid-19 pandemic is adding insult to injury.
|Empower Yourself by Understanding the Challenges of Prostate Cancer|
Chelsie Ferrell, PA, physician assistant with Advanced Urology Institute, presenting an overview of prostate cancer, treatments and disease progression. PHEN's Dr. Keith Crawford is the moderator.
|Daddy's Boys Episode 11: Helping a cousin diagnosed with prostate cancer|
Using their knowledge as PHEN ambassadors, Daddy's Boys counsel and advise their cousin Jabari who is diagnosed with prostate cancer.
|Prostate Cancer Treatment: Importance of Clinical Trials|
Elisabeth Heath, MD, FACP presented at PHEN's 17th Annual African American Disparity Summit why clinical trials are so important.
|Social Determinants of Health|
Magnolia Contreras, MSW, MBA, Vice President for Community Health, Dana-Farber Cancer Institute discusses Social Determinants of Health and the Impact on the Prostate Cancer Racial Disparity
|Considerations for the Management of Advanced Prostate Cancer|
"New effective drugs are coming, and more data is continually needed for minority populations." Presentation by Jacob Berchuck, MD (Dana-Farber).
|PHEN Community Outreach and Initiatives|
Dr. Alyn Waller (Philadelphia, PA), Dr. Dwight Jones (Richmond, VA) and Mr. Donald Jones (Pennsylvania, PA) discuss PHEN's strong partnerships with churches and other community organizations.
|PHEN Survey Results of Black Patients’ Experiences and Perspectives on Telemedicine|
Patient education is needed for telemedicine to have a major impact on eliminating the racial disparity, presented by Keith Crawford, MD, PhD
|The COVID-19 Pandemic and Increased Telemedicine Use for Prostate Cancer|
Telehealth has the potential to reduce racial disparity in prostate cancer; however, telehealth, like all healthcare is dependent on...
|Daddy's Boys Reach out as PHEN ambassadors, and Charles Love Triangle Tightens|
Junior and Uncle Bae Bae take their mission as PHEN ambassadors to the streets. Charles love triangle entanglement gets tighter.
|Summit Session 4: Social Determinants of Health, Financial Toxicity, Policy Initiatives and the Racial Disparity|
This sessions provides an understanding about social determinants of health, factors impacting prostate cancer racial disparity, costs of treatment and important policy initiatives.
|Summit Session 3: Enhancing Early Detection, Treatments and Clinical Trials Education|
Innovative tools and approaches to enhance patient education have been launched by PHEN to facilitate informed shared decision-making by empowering patients and doctors.
|Summit Session 2 Recording: Effective Prostate Cancer Community Awareness, Outreach and Engagement |
Efforts to raise awareness and mobilize support within communities nationwide will be presented and discussed. Includes doctors, patients, community and political leaders.
|Summit Session 1 Recording: What Will Be the Impact of Telemedicine? PHEN's Prostate Cancer Disparity Summit|
The COVID-19 pandemic led to dramatic increases in telemedicine use to provide prostate cancer care without in-person contact risks. It is now anticipated that telemedicine will become more of a standard of care with its use continuing to grow.
|Daddy's Boys become PHEN Ambassadors, and Charles faces a love triangle|
Pops leads the way in becoming a PHEN ambassador during meeting with PHEN President Thomas Farrington. Charles' old girlfriend, Loretta, returns in a professional relationship with Pepples, his new love.
|Leader Rev. Dr. Mark Whitlock Joins the Prostate Cancer Disparity Rally|
Senior Pastor from Reid Temple AME Church in Glenn Dale, MD shares his experience of prostate cancer and encourages African American men to get screened.
|The Cancer Health 25: Black Lives Matter|
PHEN's Thomas Farrington is named as one of Cancer Health Magazine's 25 "change makers" who are fighting to break down barriers to the best cancer care for all Americans.
|African American Prostate Cancer Disparity Rally - An Update on Activities|
Washington DC, Maryland and Virginia (DMV) campaign features messgaes from clergy, medical, congressional leaders and patients on radio stations and social media.
|Designing Immune Cells to Hunt Down Prostate Cancer|
Increasing numbers of clinical trials look at new ways to harness power of your immune system.
|Webinar: "Prostate Cancer Risk Levels & Treatment Options"|
A presentation and round-table with prostate cancer survivors exploring their experiences when initially diagnosed and identifying risk levels and treatment options using PHENPath.com.
|Daddy's Boys Genetic testing results, early detection and the return of Loretta|
Pops gets the results of his genetic testing. The merits of early detection testing is discussed using barbershop vernacular, and Charles finds out that Loretta is coming back to town.
|Church Leader Shares His Experience with Prostate Cancer|
Rev. Dr. Howard-John Wesley, Senior Pastor at Alfred Street Baptist Church talks about his prostate cancer risk and encourages all men to fight prostate cancer right now!
|Congressional Leaders Join PHEN's Prostate Cancer Disparity Rally|
COVID-19 is not the only disease ravaging the black community. So is prostate cancer. Congressman Gregory Meeks, member of the U.S. Congressional Black Caucus joins PHEN in encouraging action.
|Building Towards Patient-Centered Pathways|
A partner organization of the Amgen Clinical Pathways initiative helps empower prostate cancer patients through PHENPath.com, the first digital treatment pathway tool of its kind.
|Black Men Have Better Outcomes with Immunotherapy Treatments for Prostate Cancer|
Certain studies show greater prostate cancer survival benefits with immunotherapies for Black men compared to White men.
|PHEN Network Member AJ Merriweather active in Jacksonville, FL|
AJ Merriweather and his wife Callie participated in a prostate health awareness in Jacksonville, The Protalks community outreach program.
|Surviving Prostate Cancer by Artie L. Shelton, MD, Veterans Health Council Director|
"I know first-hand that a prostate cancer diagnosis is frightening for men and their loved ones, but you can beat this disease with early detection and learning about treatment options......."
|Webinar: "Understanding Where You Are On Your Prostate Cancer Journey"|
This March 31 webinar featured a patient roundtable discussion with prostate cancer survivors Sherman Womack, Dewayne Charleston, Henry Turner and Dr. Keith Crawford as moderator.
|Recommendations seek to reduce racial bias in cancer care|
The National Comprehensive Cancer Network, American Cancer Society Cancer Action Network and National Minority Quality Forum have released a series of recommendations aimed at improving equity in cancer care.
|Understand Your Prostate Cancer Risk Level|
Risk levels are determined by PSA Numbers, Biopsy Results, Gleason Scores, Grade Groups and Cancer Stage.
|Farrington Supports Dana-Farber's COVID-19 Vaccine Outreach|
Appears in Video focused on communities of color
|The Biden Administration Must Increase Access to Prostate Cancer Care for Black Men|
PHEN PresidentThomas Farrington urges the Biden Administration to prioritize increasing access to prostate cancer care for Black men in the fight towards health equity.
|Rev. Dr. Henry Davis Public Service Announcement|
Rev. Dr. Henry Davis, III, Senior Pastor of First Baptist Highland Park Church in Maryland introduces PHEN.
|Dr. Arthur Burnett, MD Public Service Announcement|
PSA Announcement from Dr. Arthur Burnett, Urologist / Professor at James Buchanan Brady Urological Institute, John Hopkins Unviersity
|Prostate Cancer Clinical Trials and Genetic Testing|
1 in 6 prostate cancers are caused by an inherited genetic mutation.
|Increasing Enrollment of Underrepresented Populations in Clinical Trials|
Society of Urologic Oncology in conjunction with the Young Urologic Oncologists . (UroToday.com)
|Medical Experts, Patients and Industry Leaders Discuss Prostate Cancer Clinical Trials|
By: Dr. Keith Crawford
PHEN Director of Clinical Trials and Patient Education
|Treatment Pathways and Treatment Options Information for Prostate Cancer Patients and Loved Ones|
PHENPath.com is now available to empower patients and their loved ones to make informed and shared-decisions with doctors.
|Effective Community Outreach and Engagement Strategies|
By: Rev. Adrian Backus
PHEN Director of Community Outreach and Engagement
|Survivor Network Spotlight: Nathanial Porter|
The COVID-19 virus -- and fear of infection -- is completely changing the lifestyle of Nathaniel Porter
|Summit Session IV: Community / Outreach Engagement|
Doctors and Church Partners from across the country discuss effective community and outreach engagement.
|PHEN Summit Session III: Treatment Disparities|
Quoc-Dien Trinh, MD, FACS, Co-Director Dana-Farber/Brigham and Women's Prostate Cancer Program, Boston, MA
|PHEN Summit Session III: Advanced Prostate Cancer Treatments|
Mark Pomerantz, MD, Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA
|Summit Session III: African American Treatment Outcomes with Equal Access|
Brent S. Rose, MD, Assistant Professor, University of California at San Diego, CA
|Summit Session III: Empowering Patients with PHENPath.com (Coming Soon)|
Mr. Thomas Farrington and Dr. Keith Crawford announce PHEN's new PHENPath.com tool that will be launched soon.
|Prostate Cancer Clinical Trials, Important Research and African American Patients Part 2|
Dr. Christian Poehlein from Merck discuss Keytruda, Dr. Charles Ryan from Clovis, Dr. Bela Denes from Amgen and patient Mr. Euvon Jones and his wife discuss their experiences.
|Prostate Cancer Clinical Trials, Important Research and African American Patients Part 1|
Clinical Trials and Diversity presentation by Dr. Andrew Coop from Pfizer, Respond study presentation by Dr. John Carpten from University of Southern California and patient Mr. Jimmy Barnes discusses his experiences.
|Summit Session 1B: Prostate Cancer Survivors and Advocates Speak on COVID-19 Impact|
Survivors and advocates provide their perspectives following the medical panel as part of session 1B of PHEN's 16th Annual Summit.
|Summit Session 1A: Top Black Doctors Provide Perspectives on COVID-19 and The Prostate Cancer Disparity|
Session 1 Part A: PHEN's "16th Annual African American Prostate Cancer Disparity Summit" features Dr. Edith Mitchell as co-moderator, Dr. Durado Brooks, Dr. J. Jacques Carter, Dr. Pamela Coleman, Dr. Curtis Pettaway, Dr. Walter Rayford, and Dr. Mack Roach.
|New Treatments and Clinical Trials: The Use of Genetic Information to Attack Cancers|
Dr. Keith Crawford, PHEN Director of Clinical Trials and Patient Education
|Genetic Testing Can Impact Your Prostate Cancer Journey|
Todd Cohen, MD, Vice President of Medical Affairs and Medical Director of Urology at Myriad Genetics
|Why African American Prostate Cancer Is a Crisis Within the COVID-19 Crisis|
By: Thomas A. Farrington, PHEN President and Founder
|Celebrating 20 Years of Prostate Cancer Survivorship on July 4th, 2020|
On July 4th, 2000 my wife Juarez and I boarded a plane in Boston, MA, launching our prostate cancer journey and changing our lives forever. My father's life was taken by prostate cancer on Christmas Eve 1999 at age 78. Three months later...
|PSA Screening for Prostate Cancer More Beneficial Than Previously Recognized|
By: Jody A. Chernow; Renal and Urology News; June 25, 2020
|Inherited mutation linked to higher prostate cancer risk in African American families|
A new study identifies an inherited genetic variant associated with higher risk of prostate cancer in men of African descent.
|Recorded Webinar: Accelerating Efforts to Address the Prostate Cancer Racial Disparity|
PHEN and its church partners discuss and outline strategies to enhance and accelerate efforts at the community level to address the prostate cancer disparity.
|Dramatic drop in cancer diagnoses amid COVID pandemic is cause for concern, doctors say|
Experts fear concerns over coronavirus has led to far too few screenings.
By Dr. Mark Abdelmalek and Lucien bruggeman
|Recorded Webinar: How COVID-19 Is Impacting Prostate Cancer Early Detection and Treatment|
A recording of PHEN's May 13th live webinar featuring prostate cancer medical specialists.
|Cancer patients face high mortality from COVID-19|
People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer
|Special Prayers and Inspirational Messages For Cancer Survivors In The COVID-19 Storm|
|Patients and Caregivers Connecting During The COVID-19 Crisis|
PHEN survey results of patients and caregivers during the COVID-19 pandemic
|The Coronavirus and Cancer Patients - A Special Video Presentation|
PHEN's Director of Clinical Trials and Patient Education, Dr. Keith Crawford, outlines the increased risks that the coronavirus poses to cancer patients. An in-depth review for prostate cancer patients.
|Daddy's Boys Stage Play Performances Postponed Due to COVID - 19|
Updated information about the new scheduling of the Daddy's Boys stage play performances due to COVID - 19.
|Regular exercise is important for good bone health.|
It increases bone mass, makes bone stronger, maintains and improves muscle strength, coordination and balance. Thus reducing the risk of fractures from falls.
|A Small Number Of Men With Prostate Cancer Are 'Super Responders' to Immunotheraphy|
Results from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options...
|Psychosocial Concerns Common After Prostate Cancer Treatment|
Psychosocial problems that adversely affect quality of life are common among men after receiving treatment for prostate cancer, and they need help....
|Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts Say|
Researchers have called for immediate action to recommend screening for prostate cancer for men with BRCA2 mutations over the age of 40.
|Increasing Diversity in Clinical Trials|
Clinical trials lead to the approval of new drugs. A recent article reported that black enrollment is extremely low; limiting our understanding of how these drugs effect blacks...
|One Two Punch could slow the spread of cancer|
There is no one pathway, which controls prostate cancer growth, more clinical trials are being designed using more than one drug. This ONE TWO punch design could slow the spread of cancer.
|Guideline Released on Addressing Osteoporosis Risk With Non-metastatic Cancer|
Cancer and therapies used to treat it may raise a patient’s risk of osteoporosis.
|Enrollment Completed for Phase 3 Trial Testing Provenge in Prostate Cancer Patients on Active Surveillance|
Dendreon Pharmaceuticals has completed patient enrollment ahead of schedule in an ongoing Phase 3 trial
|PHEN “Daddy’s Boys” Performance a Hit in Boston|
Boston was the 14th city where the play has been performed and the audience numbered 500.
|PHEN Hosts Workshop In Boston|
PHEN hosted an educational workshop. Dr. J. Jacques Carter, Beth Israel Deaconess Hospital and Dr. Jairam Eswara from St. Elizabeth’s Medical Center were the presenters
|Daddy's Boys Play Highlights Black Men and Prostate Cancer|
PHEN President Thomas Farrington discusses how the play addresses the prostate cancer crisis among black men on Boston Network News Television (BNNT)
|Congressman Gregory W. Meeks Presents at African-American Prostate Cancer Disparity Summit|
Congressman Gregory W. Meeks presents at PHEN's Fifteenth Annual African-American Prostate Cancer Disparity Summit.
| The African American Disparity - Biology or Access?|
Daniel George MD (Duke) and Brandon Mahal MD (Dana-Farber) speak on unequal access to treatment and biological/genetic differences.
|Increasing African American Participation in Clinical Trials|
Keith Crawford MD PhD (PHEN) and panelists discuss strategies towards increasing diversity in clinical trials enrollment.
|New Developments in Prostate Cancer Treatment|
Richard Lee MD PhD (Mass General) presents an update of the prostate cancer treatment paradigm with panelists.
|An Initiative to Address Veterans Needs|
Mr. Arnold J. Merriweather, a Vietnam Veteran, speaks on his efforts in Jacksonville, FL with veterans in the fight against prostate cancer.
|Erleada Approved for Metastatic Castration-Sensitive Prostate Cancer|
The FDA has approved the supplemental New Drug Application for Erleada (apalutamide; Janssen) for the treatment of patients with Metastatic Castration-Sensitive Prostate Cancer.
|PHEN Presents "Daddy's Boys" A Broadway-Style Stage Play at the John Hancock Hall Boston, MA|
On Saturday, October 19, 2019, at 6 PM, PHEN is bringing "Daddy's Boys" to Boston. Get tickets here.
|Friday, Sept 13 Summit Program|
The summit convened prostate cancer survivors and medical, community, industry and policy leaders to address issues towards eliminating the prostate cancer racial disparity.
|Thursday, September 12 Summit Program|
The summit convened prostate cancer survivors and medical, community, industry and policy leaders to address issues towards eliminating the prostate cancer racial disparity.
|Body fat may predict aggressive prostate cancer|
Excess weight not only raises your risk of prostate cancer, it can also mean more aggressive and fatal cancer.
|Skeletal-Related Events Common After CRPC Development |
Men with prostate cancer have a 40% cumulative incidence of first skeletal-related events (SREs) following development of castration-resistant disease
|Quality of Life Outcomes Comparable Regardless of Treatment With HRT or CRT for Low-Risk Prostate Cancer|
Hypofractionated radiotherapy is noninferior to conventional radiotherapy for quality-of-life outcomes among men with low-risk prostate tumors.
|Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking|
The Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilots. A new investigation by McClatchy shows just how serious the problem may be.
|August 14th Webcast: Prostate Cancer and the Impact on Bone Health|
Guest Speaker: Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education
Jesse Penn's story highlights the importance of prostate cancer survivors knowing about their bone health.
|Clinical Trials: Another Treatment Option for Patients - Thomas Farrington Interview with URO Today|
PHEN President Tom Farrington talks to Dr. Alicia Morgans, Assoc. Professor of Medicine at the Northwestern University Feinberg School of Medicine on how to engage best with patients.
|FDA approves Bayer’s Nubeqa®, a new treatment for men with non-metastatic castration-resistant prostate cancer |
Nubeqa was approved under the FDA’s Priority Review designation; approval granted three months ahead of target FDA action date.
|Highly Successful Daddy's Boys Stage Play in New Orleans, LA|
PHEN presented the “Daddy’s Boys" stage play on June 29th at the Southern University of New Orleans.
|New BRCA Blue campaign educates about the link between BRCA gene mutations and cancer |
Prostate Conditions Education Council in partnership with other leading prostate cancer advocacy organizations, announces the launch of the BRCA Blue Campaign.
|Prostate Cancer ADT Raises Dementia Risk, Study Finds |
Men who receive androgen deprivation therapy for prostate cancer are at increased risk for dementia, according to a new study.
|Big Jump in Active Surveillance for Low-Risk Prostate Cancer|
New findings show a dramatic increase in the number of men taking a conservative approach to low-risk prostate cancer.
|Black Race Not Associated With Higher Prostate Cancer Death Risk|
Black men with nonmetastatic prostate cancer do not appear to have worse survival than their white counterparts.
|AME Church Bishops Partner With PHEN On Prostate Cancer Education|
Bishops Harry Seawright and Adam J. Richardson, Jr. joined efforts with PHEN to expand prostate cancer outreach within their districts
|Churches Are Supporting PHEN Efforts by Hosting Daddy's Boys Stage Play |
Churches across the country are supporting PHEN efforts to raise prostate cancer education and awareness by hosting the Daddy's Boys stage play performances within their communities.
|Bethel AME Church Los Angeles to Host 6th Consecutive Symposium|
Bethel AME Los Angeles continues its strong commitment towards education and awareness under the leadership of pastor Rev. Dr. Calloway who is also a member of the PHEN Network.
|Biomarker Testing Needed Before African American Patients Choose Active Surveillance|
Thomas Farrington, PHEN President, outlines why genomic biomarker testing is needed by African American patients before they choose active surveillance....
|May 8th Webcast: Biomarker Testing Needed Before Making Treatment Decisions|
Guest Speaker: Dr. Todd D. Cohen, Medical Director at Myriad Genetics
|Evidence Supports Stereotactic Body Radiotherapy as a Standard of Care for Localized PC|
Evidence supports stereotactic body radiotherapy — a highly precise radiation therapy delivered in shorter periods of time — as a standard treatment for people with localized prostate cancer.
|Innovative Format is Key to Reaching & Educating African Americans About Prostate Cancer|
The “Daddy’s Boys” stage play, presented on tour by PHEN, draws 1,000+ national attendees per performance.
|Prostate cancer diagnoses, deaths decreasing worldwide|
Prostate caner, one of the deadliest forms of cancer for men in the United States and worldwide, is on the decline.
|African American Men Respond Better to Treatments For Advanced Prostate Cancer in Clinical Trials|
New research shows that African American men who receive treatments for late-stage prostate cancer can live at least as long, or even longer than their Caucasian counterparts.
|Better Survival for African-Americans with Metastatic Prostate Cancer|
African-American men with metastatic castration-resistant prostate cancer and no chemotherapy lived significantly longer than white men when treated with newer hormonal therapies.
|Your Risk Of Prostate Cancer Just Dropped Precipitously, Here's Why|
Most men diagnosed with Prostate Cancer don't die of the disease.
|Certain Factors Impact Treatment Selection in Advanced Prostate Cancer |
A patient's race, income level, geographic area of residence, and whether mangement is conducted may influence the type of treatment administered.
|PSA Testing Cuts Deaths, Shows Value of Long-Term Screening|
A blood test measuring the levels of PSA cuts deaths from the disease by nearly 30%.
|Xtandi Delays Disease Progression, Death in Metastatic Hormone-Sensitive PC Patients, Trial Shows|
Xtandi Delays Disease Progression, Death in Metastatic Hormone-Sensitive PC Patients.
|Newer mCRPC Drugs Led to Longer Survival in African American Patients|
Newer mCRPC Drugs Led to Longer Survival in African American Patients.
|More Men With Low-Risk Prostate Cancer Are Forgoing Treatment|
More men with low-risk prostate cancer are forgoing treatment for active surveillance.
|Comorbidities Adversely Linked to Cancer Trial Participation|
For cancer patients, the presence of comorbidities is adversely linked to trial discussions, trial offers, and trial participation.
|Finasteride shows long-term safety, efficacy for prostate cancer prevention|
Finasteride safely and effectively prevented prostate cancer, despite previous findings that suggested the drug increased the risk for high-grade disease.
|Black men with low-risk prostate cancer have higher mortality rate|
Black men diagnosed with low-risk prostate cancer may have more aggressive forms of the disease than nonblack men with the same diagnosis.
|January Webcast: Clifford D Gluck, MD, FACS|
Dr. Clifford Gluck presents webinar on the Treatmen of Stress Urinary Incontinence and Rejuvenation of Erectile Function.
|PHEN Introduces Find Your Trial (FYT) Search Tool |
Dr. Arash Eshraghi presents the FYT search tool to help those diagnosed with prostate cancer find clinical trials based on their prostate cancer stage
|PHEN Kicks-Off 2019 Tour to Sold Out Shows|
PHEN brought the acclaimed Broadway-style stage play "Daddy's Boys" to Riverside EpiCenter in Atlanta GA on Saturday, January 12.
|Daddy's Boys Feedback and Comments|
Read what audience members feedback and comments were from the Riverside Epicenter in Atlanta GA on January 12 said.
|Dec 12th Webcast: Celebrating the Blessings of Church Partnerships|
Pressentations by Rev. Adrian Backus (PHEN) and Rev. Joseph Deck (Reid Temple AME Church, MD)
|November Webcast: Understanding Progression of Prostate Cancer|
David Russell, MD from Pfizer US Medical Affairs
|Gleason 6 Prostate Cancer More Lethal in Black Men|
Black men are more likely than white men to die from Gleason 6 (low-risk) prostate cancer, according to investigators.
|PHEN Receives Healthy Churches 2020 Best Practices Award|
PHEN Honored by The Balm in Gilead with Healthy Churches 2020 Best Practice Award
|Prostate Cancer Linked to Greater Fat, Fatty Acid Intake|
Greater intake of some fatty acids is associated with a higher risk of prostate cancer
|Barriers to Prostate Cancer Research in Black Men Identified|
Investigators identified genomic testing barriers including a lack of terminology understanding, health care system mistrust, and other factors.
|Clinical Trials e-Newsletter October|
RESPOND Study, Darolutamide and Rubraca
|Dr. Artie Shelton Speaks to Men and Women Groups in Alexandria, VA|
Dr. Artie Shelton spoke at the Bethlehem Baptist Church Annual Men's and Women's Day in Alexandria, VA.
|October Webcast: Advances in Radiation Therapy for Prostate Cancer|
Guest Presenter: Peter F Orio III, DO, MS
|Boosting African American participation in prostate cancer clinical trials|
Article featured in ChangeTogether.com highlights PHEN efforts to increase African American participation in prostate cancer clinical trials.
|PHEN successfully Launches Social Media Initiative at Annual Summit|
More than 8,000 viewers tuned into the 14th Annual Summit as PHEN launched new Social Media Initiative with church partners.
|Clinical Trials e-Newsletter for July|
Clinical Trials For New Classes of Drugs in the Fight Against Prostate Cancer
|Study On Aggressive Prostate Cancer In African-American Men Launched|
A coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men
|PHEN’s 10th Annual Father’s Day Rally Grows and Expands National Outreach|
PHEN is proud to present the "10th Annual Father's Day Rally Against Prostate Cancer" on Father’s Day, June 17th, 2018..
|The Connection Between Genetics and Prostate Cancer Focusing On BRACA Gene Mutations|
June 13th webcast presentation by Karen Copeland, MS, MBA, Certified Genetic Counselor with Myriad Genetics Laboratory, Urology Department.
|Blacks With Advanced Prostate Cancer May Fare Better Than Whites|
"study underscores the importance of increasing the participation of racial minorities in clinical trials..."
|PHEN Entertains & Educates with “Daddy’s Boys” Stage Play|
PHEN presented “Daddy’s Boys" stage play on May 12 at Reid Temple AME Church in Glenn Dale, MD before an audience 1,000 plus. It was exciting & a highly successful community based prostate cancer education & awareness event.
|Diet, Exercise With Behavioral Counseling Can Reduce ADT Side Effects|
A personalized exercise and diet intervention can lead to clinical improvement.
|BRCA Mutations Up Risk for Prostate Cancer|
Males with BRCA mutations have increased incidence of malignant disease.
|Daddy’s Boys – a new play tackling prostate cancer disparity in African-American men|
Astellas Pharma highlights PHEN's "infotainment" initiative in its Change Together online portal
|Prostate Cancer: ADT Plus Docetaxel May Improve 12-Month Quality of Life|
Androgen-deprivation therapy (ADT) with docetaxel may improve quality of life (QoL) at 12 months among patients with metastatic hormone-sensitive prostate cancer
|Xtandi Reduces Risk of Metastasis in Castration-resistant Prostate Cancer|
Treatment with Xtandi (enzalutamide) reduced the risk of metastasis or death in castration-resistant prostate cancer (CRPC) patients whose cancer has not yet spread beyond the prostate.
|Patients should "Ask-In" on clinical trials participation|
African American participation in prostate cancer clinical trials must move from 3-5% range to 10-12% range to determine the effectiveness of new treatments.
|Two new treatments have been found for prostate cancer patients who previously had no effective treatment options|
Clinical trials have found that Enzalutamide and Apalutamide are both able to significantly delay prostate cancer progression in men with non-metastatic castration-resistant prostate cancer.
|Survivor Network Spotlight - Raymond Fuller, Jr.|
During a regular check-up in 2008, Ray Fuller was diagnosed with prostate cancer. There was no family history of the disease, he said, it “just popped up.”
|How dietary fat helps prostate cancer to spread|
New research demonstrates how the fat contained within the Western diet, in combination with genetic factors, can cause prostate cancer tumors to spread.
|Survivor Network Spotlight - Robbie Robinson|
There is no good time to get such news, but it was particularly jarring when Robbie Robinson was diagnosed with prostate cancer in 2002.
|Turmeric, red grape, and apple compounds 'starve' prostate cancer cells|
According to a new study, turmeric, apples and grapes could hold key to preventing and treating one of the most common cancers.
|Mediterranean Diet Best for Lowering Aggressive Prostate Cancer Risk|
Simply consuming fruits, vegetables, and whole grains might not sufficiently protect men from aggressive prostate cancer. (PCa)
|Smaller Difference in Prostate Cancer Death Risk Found|
New research shows that prostate cancer (PCa) mortality risk is lower after radical prostatectomy compared with radiotherapy, but the difference in risk is much smaller than found in previous studies.
|Blood Test Performs as Well as Tissue Biopsy in Characterizing Prostate Cancer, Study Finds|
A blood test may one day replace tumor tissue sampling for patients with prostate cancer.
|Shorter but Higher-dose Radiation Course Cuts Risk of Prostate Cancer Returning|
Delivering radiation in a shorter time frame significantly reduced the chance of prostate cancer returning in men with an intermediate-risk form of the disease, a study found
|Xtandi Does Not Increase Seizure Rates in At-Risk Metastatic Prostate Cancer Patients|
Safety study into treatment of mCRPC patients with Xtandi found therapy does not increase seizure rates.
|Preference for preserving sexual function not strongly reflected in treatment choices|
In a survey of nearly 1,200 men who have prostate cancer, more than half indicated that preserving sexual function was "very important" to them.
|How African-American Men Can Beat the Odds Against Prostate Cancer|
"The incidence of prostate cancer is over 60 percent higher in African-American men compared to white men, and in terms of mortality, it's 150 percent higher," says Thomas Farrington.
|Radiotherapy or Prostatectomy? |
Quality of Life is better after modern radiotherapy compared with surgery according to recent studies.
|Surgery vs Radiation for High-Risk Prostate Cancer|
High-risk prostate cancer (PCa) is well defined, but opinions vary on whether radical prostatectomy or radiation therapy is the best treatment approach.
|Connecting the dots between weight loss and prostate cancer|
U.S. veterans help shed light on link between dropping pounds and slowing progression of the disease
|2017 African American Prostate Cancer Disparity Summit Videos|
All presentations from PHEN's 2017 Summit program are available via videos...
|PHEN President & Founder Received an Award from Congressman Gregory Meeks (NY)|
Thomas A. Farrington, was presented with the Congressional Black Caucus Leadership Award by Congressman Gregory Meeks (NY) at PHEN's 13th Annual Summit.
|Common factors that could change your PSA test results|
How the test works and why different factors such as prescription medications and infections can change your PSA test results.
|SpaceOAR Protects Surrounding Prostate Tissues|
Augmenix's SpaceOAR System can effectively protect the rectum of prostate cancer patients undergoing high dose stereotactic body radiation therapy (SBRT).
|2017 African American Prostate Cancer Disparity Summit was a success|
In September at the 2017 African American Prostate Cancer Disparity Summit, Gary L. Taylor, M.D., the Medical Director for PHEN's Clinical Trials Rally updated everyone on the successful first phase of the Clinical Trials Rally and had several prestigious speakers talk about the importance of continuing the commitment of the Clinical Trials Rally
|PHEN Expands National Educational Outreach |
With twelve symposiums in nine states completed from April through June, and another 13 scheduled through November, the Prostate Health Education Network (PHEN) is taking its educational efforts to greater heights.
|Our Journey to Establish Prostate SBRT as a Standard of Care|
SBRT is a unique modality of radiation treatment. Typically, radiation therapy is delivered in many small doses called fractions (often 40 or more), but studies have been created to explore the possibility of delivering radiation in fewer...
|Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men|
African American men appear to be more likely to consider economic factors in their decsion-making.
|Major League Baseball Goes Blue Blue For Prostate Cancer Awareness|
Major league teams participated on Father's Day awareness effort.
|PHEN Network Member Arnold Merriweather Father's Day Interview|
Arnold J. Merriweather president of the Black Male Prostate Cancer Coalition in Jacksonville, Fl., and PHEN Network member speaks about the importance of faith in his prostate cancer journey.
|June Webcast - Prostate Cancer: Breaking The Silence|
A panel discussion with survivors, wives and church leaders.
(Use Internet Explorer, Firefox or Safari browsers, Do NOT use Google Chrome browsers)
|BBN News Interview: Thomas A Farrington Discuss PHEN 2017 Symposium and Father's Day Rally |
|Emotionally Distressed Prostate Cancer Patients May Ask for Overly Aggressive Therapy|
|Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer|
|PSA Screening Rates Level Off in United States|
The USPSTF recommended against PSA testing for men of all ages in 2012.
|African Americans at Higher Risk of Metastatic Prostate Cancer|
African American men have a higher incidence of preclinical prostate cancer and are more likely to progress to metastatic disease.
|Prostate Cancer?s Aggressive Nature in Black Americans Suggests Need for More Personalized Screening|
The higher rates at which black men are dying of prostate cancer may be linked to faster disease progression, according to a new study.
|No Menthol Sunday|
Join us on May 28, 2017 in this faith movement for health
|Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer|
Active surveillance is an alternative strategy to undergoing surgery or radiation for men with low-grade prostate cancer...
|The PHEN Network In Action Spotlight: Bishop Bob Jackson|
Bishop Bob Jackson is a prostate cancer survivor and
senior pastor at "Act Full Gospel church of God In Christ" in Oakland, CA
|Bishop Jackson's Ongoing Impact On Prostate Health In Oakland|
By: Michael Shaw, Director of the Alameda County, CA (Oakland) Office of Urban Male Health
|Meet Three Women Who Transformed Their Husbands Prostate Cancer Fight|
Women play an important role when their loved ones are faced with prostate cancer. A Media Planet article distributed in the September 2nd USA Today newspaper.